Literature DB >> 21742810

Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection.

M Lagnese1, E S Daar, P Christenson, G Rieg.   

Abstract

Herpes simplex virus type 2 (HSV-2) HIV co-infection is common and associated with increased risk of HIV transmission. HSV-2 seroprevalence was assessed on stored samples from baseline and one year follow-up from 81 patients identified with acute HIV infection and 81 age-matched chronically infected men. HSV-2 seroprevalence at baseline was lower for those with acute rather than chronic HIV-infection, 51.9 versus 71.6% (P = 0.01); relative risk 0.72 (95% confidence interval [CI] 0.57-0.92). Since HSV-2 seroprevalence is lower in those newly HIV-infected, the diagnosis of early HIV infection may allow for counselling to reduce subsequent HSV-2 acquisition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742810      PMCID: PMC4313875          DOI: 10.1258/ijsa.2011.010551

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  11 in total

1.  Recommendations for the selective use of herpes simplex virus type 2 serological tests.

Authors:  Sarah L Guerry; Heidi M Bauer; Jeffrey D Klausner; Barbara Branagan; Peter R Kerndt; Barbara G Allen; Gail Bolan
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

2.  Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons.

Authors:  Meghna Ramaswamy; Caroline Sabin; Candice McDonald; Melvyn Smith; Chris Taylor; Anna Maria Geretti
Journal:  Sex Transm Dis       Date:  2006-02       Impact factor: 2.830

3.  Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis.

Authors:  Anna Wald; Katherine Link
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

4.  Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting.

Authors:  D B Russell; S N Tabrizi; J M Russell; S M Garland
Journal:  J Clin Virol       Date:  2001-10       Impact factor: 3.168

5.  Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network.

Authors:  E S Daar; S Little; J Pitt; J Santangelo; P Ho; N Harawa; P Kerndt; J V Glorgi; J Bai; P Gaut; D D Richman; S Mandel; S Nichols
Journal:  Ann Intern Med       Date:  2001-01-02       Impact factor: 25.391

Review 6.  Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.

Authors:  Connie L Celum; Noah J Robinson; Myron S Cohen
Journal:  J Infect Dis       Date:  2005-02-01       Impact factor: 5.226

7.  Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies.

Authors:  Gunter Rieg; Roger J Lewis; Loren G Miller; Mallory D Witt; Mario Guerrero; Eric S Daar
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

8.  Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Authors:  Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study.

Authors:  D Siegel; E Golden; A E Washington; S A Morse; M T Fullilove; J A Catania; B Marin; S B Hulley
Journal:  JAMA       Date:  1992-10-07       Impact factor: 56.272

10.  Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.

Authors:  Edward R Cachay; Simon D W Frost; Douglas D Richman; Davey M Smith; Susan J Little
Journal:  J Infect Dis       Date:  2007-03-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.